Skip to main content

Table 3 90-Day clinical outcomes among 55 study patients

From: Levels and values of lipoprotein-associated phospholipase A2, galectin-3, RhoA/ROCK, and endothelial progenitor cells in critical limb ischemia: pharmaco-therapeutic role of cilostazol and clopidogrel combination therapy

Variables Day 0 Day 90 p-value
Mean ulcerative wound (grading) 2.90 ± 1.60 2.11 ± 1.64 < 0.001
Painful sensation due to CLI 92.7% (51) 19.8% (17) < 0.001
90-day individual clinical outcome    
Gastric ulcer with bleeding   1.8% (1)  
Status of CLI (90-day end point)    
Amputation due to worsening CLI   10.9% (6)  
Stationary*   34.6% (19)  
Greater improvement†   23.6% (13)  
Complete healing   16.4% (9)  
Withdraw   5.5% (3)  
Sepsis-cause death   5.5% (3)  
Cardiovascular-caused death   1.8% (1)  
Cancer-cause death   1.8% (1)  
  1. Data expressed as mean ± SD or% (n).
  2. *Defined as the ulcerative wound had more clean without progressive worsening.
  3. †Defined as the ulcerative wound healing with > 50% of the area.